Skip to main content
Top
Published in: Tumor Biology 12/2016

01-12-2016 | Original Article

MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population

Authors: Jingjing Cao, Chenglin Luo, Rui Peng, Qiaoyun Guo, Kaijuan Wang, Peng Wang, Hua Ye, Chunhua Song

Published in: Tumor Biology | Issue 12/2016

Login to get access

Abstract

RAD51, RAD52, and XRCC2 are all involved in DNA homologous recombinational repair, and there are interactions among those genes. Polymorphisms in 3′-UTR of DNA repair genes may change DNA repair capacity by regulating gene expression. However, potential regulatory variants affecting their expression remain largely unexplored. Five miRNA-binding site SNPs (rs7180135 and rs45549040 in RAD51, rs1051669 and rs7963551 in RAD52 and rs3218550 in XRCC2) selected by bioinformatics method were genotyped in 498 breast cancer (BC) patients and 498 matched controls in Chinese population. Association between SNPs and BC risk was analyzed by adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) in unconditional logistic regression model. Quantitative real-time (qRT) PCR and Western Blot assays were used to calculate the relative expression of RAD52 in recombinant plasmid-pGenesil-1-let-7b group and let-7b-inhibitor group. Gene–reproductive factors interactions were evaluated by multifactor dimensionality reduction (MDR) method. We found that individuals with AC (OR 0.684, 95%CI 0.492–0.951) and CC (OR 0.317, 95%CI 0.200–0.503) genotypes of rs7963551 had a significantly lower risk of breast cancer and qRT-PCR and Western Blot revealed that let-7b might downregulate the expression of RAD52 in MCF-7 and SKBR-3 cells. A significant interaction between the number of pregnancy (≥2) and rs7963551 (Ars7963551) was found to increase breast cancer risk by 2.63-fold (OR 2.63; 95%CI 2.03–3.42). In summary, the miRNA-binding SNPs in DNA repair genes RAD51, RAD52, and XRCC2 and their interaction with reproductive factors might play important roles in the development of BC, and let-7b might downregulate RAD52 expression in MCF-7 and SKBR-3 cells.
Literature
7.
go back to reference Dekanty A, Barrio L, Milan M. Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of drosophila epithelial cells. Oncogene. 2015;34(8):978–85. doi:10.1038/onc.2014.42.CrossRefPubMed Dekanty A, Barrio L, Milan M. Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of drosophila epithelial cells. Oncogene. 2015;34(8):978–85. doi:10.​1038/​onc.​2014.​42.CrossRefPubMed
9.
go back to reference Chatterjee S, Pal JK. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biology of the cell/under the auspices of the European Cell Biology Organization. 2009;101(5):251–62. doi:10.1042/BC20080104.CrossRef Chatterjee S, Pal JK. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biology of the cell/under the auspices of the European Cell Biology Organization. 2009;101(5):251–62. doi:10.​1042/​BC20080104.CrossRef
10.
go back to reference Zhang W, Liu J, Wang G. The role of microRNAs in human breast cancer progression. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(7):6235–44. doi:10.1007/s13277-014-2202-8.CrossRef Zhang W, Liu J, Wang G. The role of microRNAs in human breast cancer progression. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(7):6235–44. doi:10.​1007/​s13277-014-2202-8.CrossRef
11.
go back to reference Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle. 2008;7(7):853–8.CrossRefPubMed Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle. 2008;7(7):853–8.CrossRefPubMed
15.
go back to reference Landi D, Moreno V, Guino E, Vodicka P, Pardini B, Naccarati A, et al. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res. 2011;717(1–2):109–15. doi:10.1016/j.mrfmmm.2010.10.002.CrossRefPubMed Landi D, Moreno V, Guino E, Vodicka P, Pardini B, Naccarati A, et al. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res. 2011;717(1–2):109–15. doi:10.​1016/​j.​mrfmmm.​2010.​10.​002.CrossRefPubMed
16.
go back to reference Joshi AD, Lindstrom S, Husing A, Barrdahl M, Vander Weele TJ, Campa D, et al. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the breast and prostate cancer cohort consortium. Am J Epidemiol. 2014;180(10):1018–27. doi:10.1093/aje/kwu214.CrossRefPubMedPubMedCentral Joshi AD, Lindstrom S, Husing A, Barrdahl M, Vander Weele TJ, Campa D, et al. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the breast and prostate cancer cohort consortium. Am J Epidemiol. 2014;180(10):1018–27. doi:10.​1093/​aje/​kwu214.CrossRefPubMedPubMedCentral
17.
go back to reference Wu Z, Wang P, Song C, Wang K, Yan R, Li J, et al. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Molecular genetics and genomics: MGG. 2015;290(3):1141–53. doi:10.1007/s00438-014-0983-5.CrossRefPubMed Wu Z, Wang P, Song C, Wang K, Yan R, Li J, et al. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Molecular genetics and genomics: MGG. 2015;290(3):1141–53. doi:10.​1007/​s00438-014-0983-5.CrossRefPubMed
21.
go back to reference Wasson MK, Chauhan PS, Singh LC, Katara D, Dev Sharma J, Zomawia E, et al. Association of DNA repair and cell cycle gene variations with breast cancer risk in northeast Indian population: a multiple interaction analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(6):5885–94. doi:10.1007/s13277-014-1779-2.CrossRef Wasson MK, Chauhan PS, Singh LC, Katara D, Dev Sharma J, Zomawia E, et al. Association of DNA repair and cell cycle gene variations with breast cancer risk in northeast Indian population: a multiple interaction analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(6):5885–94. doi:10.​1007/​s13277-014-1779-2.CrossRef
23.
go back to reference Maacke HJK, Opitz S, Miska S, Yuan Y, Hasselbach L, Lüttges J, Kalthoff H, Stürzbecher HW. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene. 2000;19(23):2791–5. doi:10.1038/sj.onc.1203578.CrossRefPubMed Maacke HJK, Opitz S, Miska S, Yuan Y, Hasselbach L, Lüttges J, Kalthoff H, Stürzbecher HW. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene. 2000;19(23):2791–5. doi:10.​1038/​sj.​onc.​1203578.CrossRefPubMed
24.
go back to reference Han H, Bearss DJ, Walden Browne L, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002;62:2890–6.PubMed Han H, Bearss DJ, Walden Browne L, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002;62:2890–6.PubMed
25.
go back to reference Connell Philipp, Jayathilak K, Haraf Danielj, Weichselbaum Ralphr, Vokes Everette, Lingen Markw. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol. 2006;28:1113–9.PubMed Connell Philipp, Jayathilak K, Haraf Danielj, Weichselbaum Ralphr, Vokes Everette, Lingen Markw. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol. 2006;28:1113–9.PubMed
28.
go back to reference Li Y, Yu H, Luo RZ, Zhang Y, Zhang MF, Wang X, et al. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. J Surg Oncol. 2011;104(6):617–22. doi:10.1002/jso.22018.CrossRefPubMed Li Y, Yu H, Luo RZ, Zhang Y, Zhang MF, Wang X, et al. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. J Surg Oncol. 2011;104(6):617–22. doi:10.​1002/​jso.​22018.CrossRefPubMed
29.
go back to reference Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, Pisters PW, et al. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther. 2007;6(5):1650–60. doi:10.1158/1535-7163.MCT-06-0636.CrossRefPubMed Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, Pisters PW, et al. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther. 2007;6(5):1650–60. doi:10.​1158/​1535-7163.​MCT-06-0636.CrossRefPubMed
30.
go back to reference Gasparinia P, Lovat F, Fassana M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, Huebner K, Croce CM. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A. 2014;111(12):4536–41. doi:10.1073/pnas.1402604111.CrossRef Gasparinia P, Lovat F, Fassana M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, Huebner K, Croce CM. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A. 2014;111(12):4536–41. doi:10.​1073/​pnas.​1402604111.CrossRef
31.
32.
go back to reference Game JC. DNA double-strand breaks and the RAD50-RAD57 genes in saccharomyces. Semin Cancer Biol. 1993;4(2):73–83.PubMed Game JC. DNA double-strand breaks and the RAD50-RAD57 genes in saccharomyces. Semin Cancer Biol. 1993;4(2):73–83.PubMed
33.
go back to reference Sung P, Trujillo KM, Van Komen S. Recombination factors of Saccharomyces cerevisiae. Mutat Res. 2000;451(1–2):257–75.CrossRefPubMed Sung P, Trujillo KM, Van Komen S. Recombination factors of Saccharomyces cerevisiae. Mutat Res. 2000;451(1–2):257–75.CrossRefPubMed
35.
go back to reference Milne GT, Weaver DT. Dominant negative alleles of RAD52 reveal a DNA repair/recombination complex including Rad51 and Rad52. Genes Dev. 1993;7(9):1755–65.CrossRefPubMed Milne GT, Weaver DT. Dominant negative alleles of RAD52 reveal a DNA repair/recombination complex including Rad51 and Rad52. Genes Dev. 1993;7(9):1755–65.CrossRefPubMed
36.
go back to reference HAYS SHARONL, Firmenich AA, MASSEY PHILIP, BANERJEE RONADIP, BERG PAUL. Studies of the interaction between Rad52 protein and the yeast single-stranded DNA binding protein RPA. Mol Cell Biol. 1998;18(7):4400–6.CrossRefPubMedPubMedCentral HAYS SHARONL, Firmenich AA, MASSEY PHILIP, BANERJEE RONADIP, BERG PAUL. Studies of the interaction between Rad52 protein and the yeast single-stranded DNA binding protein RPA. Mol Cell Biol. 1998;18(7):4400–6.CrossRefPubMedPubMedCentral
37.
go back to reference New JH, Sugiyama T, Zaitseva E, Kowalczykowski SC. Rad52 protein stimulates DNA strand exchange by Rad51 and replication protein a. Nature. 1998;391(6665):407–10. doi:10.1038/34950.CrossRefPubMed New JH, Sugiyama T, Zaitseva E, Kowalczykowski SC. Rad52 protein stimulates DNA strand exchange by Rad51 and replication protein a. Nature. 1998;391(6665):407–10. doi:10.​1038/​34950.CrossRefPubMed
39.
go back to reference Xia Y, Zhu Y, Zhou X, Chen Y. Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(6):5143–8. doi:10.1007/s13277-014-1663-0.CrossRef Xia Y, Zhu Y, Zhou X, Chen Y. Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(6):5143–8. doi:10.​1007/​s13277-014-1663-0.CrossRef
40.
go back to reference Han S, Gao F, Yang W, Ren Y, Liang X, Xiong X, Pan W, Zhou L, Zhou C, Ma F, Yang M. Identification of an SCLC susceptibility rs7963551 genetic polymorphism in a previously GWAS-identified 12p13.33 RAD52 lung cancer risk locus in the Chinese population. Int J Clin Exp Med. 2015;8(9):16528–35.PubMedPubMedCentral Han S, Gao F, Yang W, Ren Y, Liang X, Xiong X, Pan W, Zhou L, Zhou C, Ma F, Yang M. Identification of an SCLC susceptibility rs7963551 genetic polymorphism in a previously GWAS-identified 12p13.33 RAD52 lung cancer risk locus in the Chinese population. Int J Clin Exp Med. 2015;8(9):16528–35.PubMedPubMedCentral
41.
go back to reference Lu C, Chen YD, Han S, Wei J, Ge Y, Pan W, et al. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese. J Neuro-Oncol. 2014;120(1):11–7. doi:10.1007/s11060-014-1527-x.CrossRef Lu C, Chen YD, Han S, Wei J, Ge Y, Pan W, et al. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese. J Neuro-Oncol. 2014;120(1):11–7. doi:10.​1007/​s11060-014-1527-x.CrossRef
42.
go back to reference Li Z, Guo Y, Zhou L, Ge Y, Wei L, Li L, et al. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma. Mol Carcinog. 2015;54(9):853–8. doi:10.1002/mc.22156.CrossRefPubMed Li Z, Guo Y, Zhou L, Ge Y, Wei L, Li L, et al. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma. Mol Carcinog. 2015;54(9):853–8. doi:10.​1002/​mc.​22156.CrossRefPubMed
43.
44.
go back to reference Naccarati A, Vodickova L, Vodicka P, Rosa F, Di Gaetano C, Gemignani F, Pardini B, Vymetalkova V, Novotny J, Buchler T, Barone E, Levy M, Landi S, LudmilaPavel K. Double-strand break repair and colorectal cancer: gene variants within 3′ UTRs and microRNAs binding as modulators of cancer risk and clinical outcome. Oncotarget. 2015;7(17):23156–69. doi:10.18632/oncotarget.6804.PubMedCentral Naccarati A, Vodickova L, Vodicka P, Rosa F, Di Gaetano C, Gemignani F, Pardini B, Vymetalkova V, Novotny J, Buchler T, Barone E, Levy M, Landi S, LudmilaPavel K. Double-strand break repair and colorectal cancer: gene variants within 3′ UTRs and microRNAs binding as modulators of cancer risk and clinical outcome. Oncotarget. 2015;7(17):23156–69. doi:10.​18632/​oncotarget.​6804.PubMedCentral
47.
go back to reference Zhang Y, Wang H, Peng Y, Liu Y, Xiong T, Xue P, et al. The Arg188His polymorphism in the XRCC2 gene and the risk of cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(4):3541–9. doi:10.1007/s13277-013-1468-6.CrossRef Zhang Y, Wang H, Peng Y, Liu Y, Xiong T, Xue P, et al. The Arg188His polymorphism in the XRCC2 gene and the risk of cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(4):3541–9. doi:10.​1007/​s13277-013-1468-6.CrossRef
49.
go back to reference Perez LO, Crivaro A, Barbisan G, Poleri L, Golijow CD. XRCC2 R188H (rs3218536), XRCC3 T241 M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk. Pathol Oncol Res. 2013;19(3):553–8. doi:10.1007/s12253-013-9616-2.CrossRefPubMed Perez LO, Crivaro A, Barbisan G, Poleri L, Golijow CD. XRCC2 R188H (rs3218536), XRCC3 T241 M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk. Pathol Oncol Res. 2013;19(3):553–8. doi:10.​1007/​s12253-013-9616-2.CrossRefPubMed
51.
go back to reference Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast cancer research: BCR. 2010;12(6):R110. doi:10.1186/bcr2797.CrossRefPubMedPubMedCentral Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast cancer research: BCR. 2010;12(6):R110. doi:10.​1186/​bcr2797.CrossRefPubMedPubMedCentral
52.
Metadata
Title
MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population
Authors
Jingjing Cao
Chenglin Luo
Rui Peng
Qiaoyun Guo
Kaijuan Wang
Peng Wang
Hua Ye
Chunhua Song
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5459-2

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine